Precipio, Inc. (PRPO)
NCM · Healthcare · Diagnostics & Research
$21.85
-3.62%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$39.1M
Shares Outstanding
1.8M
P/S (TTM)
1.5x
Exchange
NCM
Currency
USD
About Precipio, Inc.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 5.7M | 6.8M | 6.7M | 6.7M |
| Gross Profit | 2.4M | 3.0M | 3.1M | 2.7M |
| Operating Income | -824K | -61K | 542K | -1.4M |
| Net Income | 74K | -79K | 526K | -1.4M |
| Diluted EPS | $0.05 | $-0.05 | $nan | $-0.81 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 9.4M | 15.2M | 18.5M | 24.0M |
| Gross Profit | 2.5M | 6.0M | 7.6M | 10.7M |
| Net Income | -12.2M | -5.9M | -4.3M | -363K |
| Diluted EPS | $-10.73 | $-4.51 | $-2.93 | $-0.23 |